|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 06/04/16 | Allergan : Obama's inversion curbs kill Pfizer's $160 billion Allergan deal | RE |
| 31/03/16 | Argus Media close to stake sale, Temasek among bidders - sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Boyer
IRC | Investor Relations Contact | - | 02/02/2014 |
Carlos Pascual
PRN | Corporate Officer/Principal | - | 11/01/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel H. Yergin
BRD | Director/Board Member | 79 | 25/11/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.51% | -2.96% | -18.95% | +7.95% | 116B | ||
| -0.15% | -4.16% | -4.69% | +43.63% | 78.65B | ||
| +1.37% | -0.24% | -36.91% | -17.95% | 42.26B | ||
| -0.20% | -3.07% | -5.07% | +4.99% | 39.16B | ||
| -2.17% | -8.00% | -34.01% | -9.18% | 28.95B | ||
| +0.09% | -1.44% | -32.36% | -10.03% | 18.19B | ||
| -2.30% | -3.87% | -42.09% | -42.39% | 17.14B | ||
| -2.55% | -11.64% | -46.50% | -25.08% | 16.12B | ||
| -2.11% | -2.78% | +9.50% | +54.55% | 16.39B | ||
| Average | -0.82% | -3.55% | -23.45% | +0.72% | 41.46B | |
| Weighted average by Cap. | -0.20% | -3.37% | -19.35% | +8.33% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















